Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

https://soho2018.org/

Session I: Chronic Myeloid Leukemia
Session II: Myelodysplastic Syndromes
Session III: Myeloproliferative Neoplasms
Session IV: Acute Lymphoblastic Leukemia
Session V: Acute Myeloid Leukemia
Plenary Sessions
Breakfast with the Expert
Session VI: Multiple Myeloma
Program of Events
Session VIII: Non-Hodgkin Lymphoma
Session IX: Chronic Lymphocytic Leukemia
Session X: Research Topics

Playback speed

10 seconds

DEBATE: Use Gemtuzumab in Most AML Patients vs Use Gemtuzumab in CBF Patients or Not at All? Pro

By Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018) FEATURING Roland B. Walter

23 views

October 24, 2018

Comments 0

New Approval for Frontline Consolidation in Patients with CD19-posit…

Feat. J. Mccloskey

Making the First Chance Count: Manuel

Feat. A. Ip

Session V: Acute Myeloid Leukemia

AML: State of the Art Update

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

H. Erba

84 views

NGS At Diagnosis: Uses And Pitfalls

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

C. Gibson

47 views

Immune Therapy Approaches in AML: Antigen Targets, Novel Antibodies …

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

N. Daver

154 views

DEBATE: Use Gemtuzumab in Most AML Patients vs Use Gemtuzumab in CBF…

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

R. Walter

23 views

DEBATE: Use Gemtuzumab in Most AML Patients vs Use Gemtuzumab in CBF…

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

G. Roboz

89 views

Durable Response with Venetoclax in Combination with Decitabine or A…

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

C. DiNardo

118 views

Oral Abstract AML 152: Hypomethylating Agents versus Intensive Chemo…

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

C. Talati

22 views

Oral Abstract SCT 020: Incidence, Risk Factors and Treatment Respons…

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

D. Rivera

24 views

AML Next Questions: MRD and Discussion Intensive Induction, Immune S…

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

R. Stone

147 views